Insider trade

Thermo Fisher Scientific (TMO)Executive Vice President sold ~$9.73M

Frederick M. Lowery, Executive Vice President at Thermo Fisher Scientific, sold ~$9.73M of Thermo Fisher Scientific shares.

~$9.73M
Approx. value · 18K sh @ $531.81: 17K
Holds after · shares reported

Traded: Feb 24, 2025
Filed: Feb 26, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

What came next

Feb 25, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
Feb 27, 2025FDAFDA device clearance: The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of 0.008-16 µg/mL
Mar 3, 2025InsiderOfficer sold ~$945K of TMO shares in the open market
Mar 3, 2025Congress · 1 personMembers of Congress: 2 purchases
Mar 4, 2025Insider · 1 personInsiders: 9 sales (~$5.2M)
Mar 5, 2025Insider · 1 personInsiders: 8 sales (~$4.2M)
Mar 10, 2025InsiderOfficer sold ~$2.01M of TMO shares in the open market
Mar 27, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
Apr 7, 2025Congress · 2 peopleMembers of Congress: 2 sales
Apr 8, 2025Congress · 2 peopleMembers of Congress: 2 sales
Apr 11, 2025Congress · 2 peopleMembers of Congress: 2 sales
Apr 15, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Moxifloxacin in the dilution range of 0.008-16 ug/mL
Apr 21, 2025Congress · 1 personMembers of Congress: 2 sales
Apr 28, 2025InsiderOfficer sold ~$129K of TMO shares in the open market
Apr 29, 2025Layoff notice · 100 West Gore Street, ORLANDO, FL, 32806Layoff notice filed in FL: 59 employees
May 5, 2025CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
May 12, 2025InsiderOfficer sold ~$164K of TMO shares in the open market
May 13, 2025CongressDisclosed purchase of TMO — reported range $15,001 - $50,000
May 15, 2025CongressDisclosed purchase of TMO — reported range $15,001 - $50,000
May 16, 2025CongressDisclosed sale of TMO — reported range $15,001 - $50,000

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Thermo Fisher Scientific

For Thermo Fisher Scientific, OQRO holds 93 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 143 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMO page.

Other recent filings by Frederick M. Lowery, Executive Vice President

The full history of Frederick M. Lowery, Executive Vice President is on the profile page.

How this filing works

Other disclosures at Thermo Fisher Scientific

Everything OQRO holds on this company is on its TMO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data